What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery or portal vein thrombosis?

Sub-questions

  • What are the optimal pharmacologic interventions for postoperative thromboprophylaxis regarding prevention of bleeding, hepatic artery or portal vein thrombosis (aspirin, heparin, epoprostanol, LMWH)?
  • Which are the optimal monitoring techniques for pharmacologic thromboprophylaxis regarding prevention of bleeding, hepatic artery or portal vein thrombosis (APTT, Xa levels, platelet function assays, TEG/ROTEM)?
  • Which are the optimal techniques and time points of postoperative imaging regarding the prevention hepatic artery thrombosis (implantable dopplers/ doppler USS)?

Scientific Committee Liaison

  • Francois Durand, Hepatology, Paris, France  

Expert Working Group Panel Members 

  • Lucas McCormack, Surgery, Buenos Aires, Argentina  
  • GiWon Song, Surgery, Seoul, Korea  
  • Patrick Northup, Hepatology, Charlottesville, VA, USA  
  • Charles Imber, Surgery, London, UK  
  • Bryan O'Farrell, Pharmacology, London, UK  

Vanguard Committee Member

  • Varvara Kirchner, Surgery, Minneapolis MN, USA  

Junior Research Committee Members

  • Stephanie Bogan, London, UK 
  • Sithhipratha Arulrajan, London, UK 

 

 Back Back to the Program                                                          Next Panel Next